Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Bluebird bio to cut 25% of jobs in fresh bid to battle cash crunch September 24, 2024 Britain's National Health Service (NHS) will begin to roll out a gene therapy from Vertex Pharmaceuticals and ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 / CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals' ...

Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

Wall Street will continue to digest the big flow of news from the last few weeks, including the Fed meeting and the recent data on inflation and jobs. The Dow Jones Industrial Average ended last ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...